The details for the Risk Adjustment Data Validation program have been finalized and adjusted. Do you think these adjustments will be beneficial to the parties involved? Share your thoughts, comments and questions below. “Medicare Advantage Risk Adjustment Data Validation Final Rule (CMS-4185-F2) Fact Sheet”  

The White House and the Cancer Cabinet are constantly making efforts to rid the world of cancer for good. Recently President Biden announced his goal to reduce the rate of cancer buy at least 50 percent in the next 25 years. Many parties will be stepping up to achieve this goal this year. Here are […]

Changes are coming to the Part D prescription drug programs in 2024. On February 1, 2023 CMS released a notice discussing these changes and more. Hopefully the changes will overall improve the relationship between the MA risk adjustment model, the payment system and ICD-10. For more information about the Advance notice, click the first link. […]

Americans pay double or even triple what other countries pay for prescription drugs. Do you fall into this category? If so, then keep reading! A new prescription drug law has been passed, when prescription drug prices rise faster than the rate of inflation drug companies will pay a rebate to the government. How do you […]